Downregulation of renal TRPM7 and increased inflammation and fibrosis in aldosterone-infused mice: Effects of magnesium

Hypertension

Volumn 51, Issue 4, 2008, Pages 915-921

  Sontia, Bruno ^a   Montezano, Augusto C I ^a   Paravicini, Tamara ^a   Tabet, Fatiha ^a   Touyz, Rhian M ^a  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

Annexin 1; Blood pressure; Cardiovascular remodeling; Cations; COX2; TRP channels; Vascular cell adhesion molecule

Indexed keywords

ALDOSTERONE; ANNEXIN; CARRIER PROTEIN; CYCLOOXYGENASE 2; DRINKING WATER; INTERLEUKIN 6; MAGNESIUM ION; MESSENGER RNA; POTASSIUM ION; SODIUM CHLORIDE; SODIUM ION; TRANSIENT RECEPTOR POTENTIAL MELASTATIN CATION CHANNEL 6; TRANSIENT RECEPTOR POTENTIAL MELASTATIN CATION CHANNEL 7; VASCULAR CELL ADHESION MOLECULE 1; MAGNESIUM; SODIUM; TRANSIENT RECEPTOR POTENTIAL CHANNEL M; TRPM7 PROTEIN, MOUSE; UNCLASSIFIED DRUG;

ABNORMAL SUBSTRATE CONCENTRATION IN BLOOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR EFFECT; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; HEART MUSCLE FIBROSIS; HEART SIZE; HYPERALDOSTERONISM; HYPERTENSION; HYPOMAGNESURIA; INFLAMMATION; KIDNEY INJURY; KIDNEY SIZE; MALE; MOUSE; NONHUMAN; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEINURIA; SODIUM BLOOD LEVEL; TREATMENT OUTCOME; ANIMAL; BLOOD; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; FIBROSIS; GENE EXPRESSION; GENETICS; IMMUNOLOGY; KIDNEY; METABOLISM; NEPHRITIS; ORGAN SIZE; PATHOLOGY; PHYSIOLOGY; URINE;

ALDOSTERONE; ANIMALS; BLOOD PRESSURE; BODY WEIGHT; DOWN-REGULATION; FIBROSIS; GENE EXPRESSION; HYPERALDOSTERONISM; KIDNEY; MAGNESIUM; MALE; MICE; MICE, INBRED C57BL; NEPHRITIS; ORGAN SIZE; SODIUM; TRPM CATION CHANNELS;

EID: 42049100585     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.107.100339     Document Type: Article

References (39)

1. Good DW. Nongenomic actions of aldosterone on the renal tubule. Hypertension. 2007;49:728-739.
2. Del Vecchio L, Procaccio M, Viganò S, Cusi D. Mechanisms of disease: the role of aldosterone in kidney damage and clinical benefits of its blockade. Nat Clin Pract Nephrol. 2007;3:42-49.
3. Sun Y, Zhang J, Lu L, Chen SS, Quinn MT, Weber KT. Aldosterone-induced inflammation in the rat heart: role of oxidative stress. Am J Pathol. 2002;161:1773-1781.
4. Iglarz M, Touyz RM, Viel EC, Amiri F, Schiffrin EL. Involvement of oxidative stress in the profibrotic action of aldosterone. Interaction with the renin-angiotension system. Am J Hypertens. 2004;17:597-603.
5. Sun Y, Ahokas RA, Bhattacharya SK, Gerling IC, Carbone LD, Weber KT. Oxidative stress in aldosteronism. Cardiovasc Res. 2006;71:300-309.
6. Wenzel U. Aldosterone antagonists: silver bullet or just sodium excretion and potassium retention? Kidney Int. 2007;71:374-376.
7. Pitt B. Effect of aldosterone blockade in patients with systolic left ventricular dysfunction: implications of the RALES and EPHESUS studies. Mol Cell Endocrinol. 2004;217:53-58.
8. Runyan AL, Sun Y, Bhattacharya SK, Ahokas RA, Chhokar VS, Gerling IC, Weber KT. Responses in extracellular and intracellular calcium and magnesium in aldosteronism. J Lab Clin Med. 2005;146:76-84.
9. Ahokas RA, Sun Y, Bhattacharya SK, Gerling IC, Weber KT. Aldosteronism and a proinflammatory vascular phenotype: role of Mg2+, Ca2+, and H2O2 in peripheral blood mononuclear cells. Circulation. 2005;111:51-57.
10. Sapna S, Ranjith SK, Shivakumar K. Cardiac fibrogenesis in magnesium deficiency: a role for circulating angiotensin II and aldosterone. Am J Physiol Heart Circ Physiol. 2006;291:H436-H440.
11. Goodwin KD, Ahokas RA, Bhattacharya SK, Sun Y, Gerling IC, Weber KT. Preventing oxidative stress in rats with aldosteronism by calcitriol and dietary calcium and magnesium supplements. Am J Med Sci. 2006;332:73-78.
12. Schmitz C, Perraud AL, Johnson CO. Regulation of vertebrate cellular Mg2+ homeostasis by TRPM7. Cell. 2003;114:191-200.
13. Schlingmann KP, Gudermann T. A critical role of TRPM channel-kinase for human magnesium transport. J Physiol. 2005;566:301-308.
14. Schmitz C, Perraud AL, Fleig A. Dual-function ion channel/protein kinases: novel components of vertebrate magnesium regulatory mechanisms. Pediatr Res. 2004;55:734-737.
15. Kozak JA, Cahalan MD. MIC channels are inhibited by internal divalent cations but not ATP. Biophys J. 2003;84:922-927.
16. Hoenderop JG, Bindels RJ. Epithelial Ca2+ and Mg2+ channels in health and disease. J Am Soc Nephrol. 2005;16:15-26.
17. Fleig A, Penner R. The TRPM ion channel subfamily: molecular, biophysical and functional features. Trends Pharmacol Sci. 2004;25:633-639.
18. Dorovkov MV, Ryazanov AG. Phosphorylation of annexin I by TRPM7 channel-kinase. J Biol Chem. 2004;279:50643-50646.
19. Su LT, Agapito MA, Li M, Simonson WT, Huttenlocher A, Habas R, Yue L, Runnels LW. TRPM7 regulates cell adhesion by controlling the calcium-dependent protease calpain. J Biol Chem. 2006;281:11260-11270.
20. Chubanov V, Waldegger S, Mederos Y. Disruption of TRPM6/TRPM7 complex formation by a mutation in the TRPM6 gene causes hypomagnesemia with secondary hypocalcemia. Proc Natl Acad Sci U S A. 2004;101:2894-2899.
21. Touyz RM, He Y, Montezano AC, Yao G. Differential regulation of transient receptor potential melastatin 6 and 7 cation channels by ANG II in vascular smooth muscle cells from spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol. 2006;290:R73-R78.
22. He Y, Yao G, Savoia C, Touyz RM. Transient receptor potential melastatin 7 ion channels regulate magnesium homeostasis in vascular smooth muscle cells: role of angiotensin II. Circ Res. 2005;96:207-215.
23. Schiffrin EL, Touyz RM. Calcium, magnesium, and oxidative stress in hyperaldosteronism. Circulation. 2005;111:871-878.
24. Yang T, Huang YG, Ye W, Hansen P, Schnermann JB, Briggs JP. Influence of genetic background and gender on hypertension and renal failure in COX-2-deficient mice. Am J Physiol Renal Physiol. 2005;288:F1125-F1132.
25. Handtrack C, Cordasic N, Klanke B, Veelken R, Hilgers KF. Effect of the angiotensinogen genotype on experimental hypertension in mice. J Mol Med. 2007;85:343-350.
26. Wang Q, Clement S, Gabbiani G, Horisberger JD, Burnier M, Rossier BC, Hummler E. Chronic hyperaldosteronism in a transgenic mouse model fails to induce cardiac remodeling and fibrosis under a normal-salt diet. Am J Physiol Renal Physiol. 2004;286:F1178 -F1184.
27. Blasi ER, Rocha R, Rudolph AE. Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats. Kidney Int. 2003;63:1791-1800.
28. Endemann DH, Touyz RM, Iglarz M, Savoia C, Schiffrin EL. Eplerenone prevents salt-induced vascular remodeling and cardiac fibrosis in stroke-prone spontaneously hypertensive rats. Hypertension. 2004;43:1252-1257.
29. Young M, Fullerton M, Dilley R, Funder J. Mineralocorticoids, hypertension, and cardiac fibrosis. J Clin Invest. 1994;93:2578 -2583.
30. Callera GE, Montezano AC, Yogi A, Tostes RC, He Y, Schiffrin EL, Touyz RM. c-Src-dependent nongenomic signaling responses to aldosterone are increased in vascular myocytes from spontaneously hypertensive rats. Hypertension. 2005;46:1032-1038.
31. Callera GE, Touyz RM, Tostes RC, Yogi A, He Y, Malkinson S, Schiffrin EL. Aldosterone activates vascular p38MAP kinase and NADPH oxidase via c-Src. Hypertension. 2005;45:773-779.
32. Manju L, Nair RR. Magnesium deficiency augments myocardial response to reactive oxygen species. Can J Physiol Pharmacol. 2006;84:617-624.
33. Mazur A, Maier JA, Rock E. Magnesium and the inflammatory response: potential physiopathological implications. Arch Biochem Biophys. 2007;458:48-56.
34. Touyz RM, Yao G. Modulation of vascular smooth muscle cell growth by magnesium-role of mitogen-activated protein kinases. J Cell Physiol. 2003;197:326-335.
35. Tejero-Taldo MI, Kramer JH, Mak IuT, Komarov AM, Weglicki WB. The nerve-heart connection in the pro-oxidant response to Mg-deficiency. Heart Fail Rev. 2006;11:35-44.
36. Kramer JH, Mak IT, Phillips TM. Dietary magnesium intake influences circulating pro-inflammatory neuropeptide levels and loss of myocardial tolerance to postischemic stress. Exp Biol Med. 2003;228:665-673.
37. Chhokar VS, Sun Y, Bhattacharya SK, Ahokas RA, Myers LK, Xing Z, Smith RA, Gerling IC, Weber KT. Hyperparathyroidism and the calcium paradox of aldosteronism. Circulation. 2005;111:830-831.
38. Lim LH, Pervaiz S. Annexin 1: the new face of an old molecule. FASEB J. 2007;21:968-975.
39. Touyz RM, Yao G. Up-regulation of vascular and renal mitogen-activated protein kinases in hypertensive rats is normalized by inhibitors of the Na+/Mg2+ exchanger. Clin Sci (Lond). 2003;105:235-242.